News about

Boehringer Ingelheim breaks ground on 285M API plant in Germany

Boehringer Ingelheim breaks ground on 285M API plant in Germany

Boehringer Ingelheim kicked off construction on a new 285 million euro ($315 million) plant at its German headquarters that will produce active pharmaceutical ingredients and drugs for clinical trials.

| 15/06/2023 | By 1121

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

| 15/06/2023 | By 541

Biogens Biologics Manufacturing Facility, Solothurn, Switzerland

Biogens Biologics Manufacturing Facility, Solothurn, Switzerland

US-based biotechnology company Biogen developed a biologics manufacturing facility in Luterbach near Solothurn, Switzerland.

| 15/06/2023 | By 1949

Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients

Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients

Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients

| 15/06/2023 | By 1627

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

| 14/06/2023 | By 966

Granules India Ltd received ANDA Approval for Metoprolol Succinate ER Tablets

Granules India Ltd received ANDA Approval for Metoprolol Succinate ER Tablets

Granules India Limited today, announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg.

| 14/06/2023 | By 666

Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam

Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam

Ipca Laboratories Limited has announced that the US FDA conducted the inspection of the Company's APIs manufacturing facility situated at Ratlam, Madhya Pradesh from 5th June, 2023 to 13th June, 2023. At the conclusion of the inspection, the US FDA issued a Form 483 with 11 (eleven) observations.<br />

| 14/06/2023 | By 1934

Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality

Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality

Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality

| 09/06/2023 | By 946

Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

| 09/06/2023 | By 487

Zydus receives final approval from the USFDA for Tadalafil Tablets USP, 20 mg

Zydus receives final approval from the USFDA for Tadalafil Tablets USP, 20 mg

Zydus receives final approval from the USFDA for Tadalafil Tablets USP, 20 mg

| 09/06/2023 | By 598

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members